This report was recently updated on December 16 2024 with the latest and most recent
market numbers
Global AI in Pathology Market Size, Trends & Analysis - Forecasts to 2029 By Component (Hardware and Software), By Neural Network (Generative Adversarial Networks (GANs), Convolutional Neural Networks (CNNs), Recurrent Neural Networks (RNNs), and Others), By Application (Drug Discovery, Disease Diagnosis & Prognosis, Clinical Workflow, and Training & Education), By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Reference Laboratories, and Academic & Research Institutes), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis
The global AI in pathology market is estimated to exhibit a CAGR of 15.7% from 2024 to 2029.
The primary factors propelling the market growth are the increasing demand for accurate and efficient diagnostic tools in pathology and the growing availability of large medical datasets for AI model training and optimization. As healthcare systems face rising patient volumes and a need for faster, more precise diagnoses, AI-powered solutions are becoming essential in enhancing diagnostic accuracy and efficiency. AI technologies, such as machine learning and deep learning algorithms, enable pathologists to process and analyze vast amounts of medical data, including imaging and genetic information, far more quickly than traditional methods. This lowers the possibility of human errors, improves patient outcomes, and leads to quicker diagnoses. Furthermore, AI's capacity to identify patterns and abnormalities that might not be immediately apparent to the human eye is very helpful in complicated situations like cancer detection. As healthcare providers seek to meet the growing demand for high-quality diagnostics, AI is increasingly seen as a critical tool in advancing pathology workflows and clinical decision-making. For instance, an estimated 800,000 Americans receive incorrect diagnoses each year, which results in 371,000 patient deaths and 424,000 lifelong disabilities, according to a 2023 BMJ-Quality & Safety article.
Advancements in machine learning (ML) and deep learning (DL) algorithms for pathology applications and the increasing healthcare investments in AI technologies are expected to support market growth. ML & DL technologies enable AI systems to learn from vast datasets of medical images, patient records, and genomic data, improving their ability to identify complex patterns and predict disease outcomes. In pathology, ML and DL algorithms can automate the analysis of tissue samples, detecting abnormalities such as tumors, infections, and genetic mutations with high precision. As these algorithms continue to evolve, they are becoming better at mimicking the diagnostic expertise of experienced pathologists, often with greater consistency and at a faster rate. Additionally, advancements in these technologies are fostering the development of AI tools that integrate with digital pathology systems, providing seamless workflows for pathologists.
Rising integration of AI with digital pathology platforms coupled with the growing focus on personalized medicine and tailored treatment strategies in pathology propel market growth. AI technologies are crucial in analyzing complex medical data, including histopathology images, genetic information, and patient demographics. These AI tools help identify specific biomarkers, genetic mutations, and disease patterns that are unique to each patient, allowing pathologists to offer customized treatment plans. As the demand for personalized medicine increases, AI's ability to support pathologists in making more accurate, data-driven decisions becomes increasingly important. With the shift toward precision healthcare, AI in pathology is becoming an integral tool in creating tailored therapeutic strategies, leading to improved patient outcomes and greater market growth.
AI in pathology opens up opportunities for telepathology and remote diagnostics, allowing pathologists to work from different locations, facilitating faster consultations, and making quality pathology services more accessible, especially in underserved regions. Additionally, AI in pathology offers opportunities to improve compliance with healthcare regulations by automating documentation, tracking, and reporting processes, helping institutions adhere to standards such as HIPAA while maintaining high levels of diagnostic accuracy.
However, raising concerns about data privacy and security and the high initial costs associated with implementing AI-driven pathology systems impede market growth.
The hardware segment is expected to hold the largest share of the market over the forecast period. AI in pathology heavily relies on advanced imaging devices, such as digital scanners, high-resolution cameras, and specialized microscopes, for accurate data capture and analysis. Additionally, AI in pathology requires powerful computing hardware to process large datasets, including high-resolution medical images. Dedicated hardware systems, like GPUs and AI accelerators, are crucial for running complex machine-learning models, contributing to the hardware segment's dominance.
The software segment is expected to be the fastest-growing segment in the market from 2024 to 2029. The growing adoption of digital pathology is fueling the need for software that can seamlessly integrate with digital imaging platforms. AI-powered software that can process, analyze, and store high-resolution pathology images is rapidly gaining traction, contributing to market growth.
The convolutional neural networks (CNNs) segment is expected to hold the largest share of the market over the forecast period. CNNs process and analyze medical pictures, including pathology slides, very effectively. Their ability to detect intricate patterns, abnormalities, and subtle changes in images is a key driver of their adoption in pathology, making them crucial for accurate diagnoses
The generative adversarial networks (GANs) segment is anticipated to be the fastest-growing segment in the market from 2024 to 2029. In rare disorders where there are limited annotated medical images, GANs can provide synthetic data to supplement datasets. This ability to generate diverse and realistic data helps train more robust models, driving the growth of GANs in pathology applications.
The drug discovery segment is expected to hold the largest share of the market over the forecast period. AI in pathology plays a critical role in identifying biomarkers that are essential for drug discovery. By analyzing pathology images, AI can uncover subtle patterns in tissues and cells, facilitating the identification of potential targets for new drugs, which drives the market's growth in this application.
The clinical workflow segment is anticipated to be the fastest-growing segment in the market from 2024 to 2029. AI in pathology is increasingly being used to automate routine tasks such as image analysis, data entry, and report generation. This automation reduces the workload of pathologists, enabling them to focus on more complex diagnostic tasks, driving rapid adoption in clinical workflows.
The hospitals & reference laboratories segment is expected to hold the largest share of the market over the forecast period. Hospitals and reference laboratories handle a large volume of pathology cases daily, creating a significant demand for AI tools that can streamline the analysis of medical images, slides, and diagnostic data. This high workload drives the adoption of AI solutions to improve efficiency and accuracy.
The pharmaceutical & biotechnology companies segment is anticipated to be the fastest-growing segment in the market from 2024 to 2029. The growing shift towards precision medicine and targeted therapies has driven pharmaceutical and biotech companies to leverage AI in pathology. By using AI to analyze tissue samples, these companies can develop more effective, personalized treatments, that address specific genetic and molecular profiles of patients.
North America is expected to be the largest region in the global market. North America is at the forefront of AI adoption across various industries, including healthcare. The region's high adoption rates of AI-driven solutions in diagnostics, particularly in pathology, are propelled by substantial research funding, a strong technology ecosystem, and an innovation-driven environment.
Asia Pacific is anticipated to witness rapid growth during the forecast period. As healthcare access expands across Asia Pacific, particularly in rural and underserved areas, the adoption of AI in pathology is increasing. AI-based diagnostic tools help bridge the gap in healthcare services by providing faster and more accurate diagnostics, even in remote regions.
Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd, Hologic, Inc., Akoya Biosciences, Inc., Aiforia Technologies Plc, Indica Labs Inc., OptraScan, Ibex Medical Analytics Ltd., Mindpeak GmbH, and Tribun Health among others, is some of the key players in the global AI in pathology market.
Please note: This is not an exhaustive list of companies profiled in the report.
In February 2024, the AI algorithm features of Hologic Inc.'s Genius Digital Diagnostics System were approved by the US Food and Drug Administration (FDA). This device is the first digital cytology solution approved by the FDA that combines deep-learning artificial intelligence with sophisticated volumetric imaging technology to help identify cervical cancer cells and precancerous lesions.
In February 2024, Roche Tissue Diagnostics (RTD) partnered with PathAI to develop AI-powered digital pathology algorithms for RTD's companion diagnostics segment. Roche's Navify Digital Pathology platform will be used to deploy these image analysis algorithms, guaranteeing a seamless integration into pathology labs worldwide.
1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS
1.1 Strategic Opportunity & Attractiveness Analysis
1.1.1 Hot Revenue Pockets
1.1.2 Market Attractiveness Score
1.1.3 Revenue Impacting Opportunity
1.1.4 High Growing Region/Country
1.1.5 Competitor Analysis
1.1.6 Consumer Analysis
1.2 Global Market Estimates' View
1.3 Strategic Insights across Business Functions
1.3.1 For Chief Executive Officers
1.3.2 For Chief Marketing Officers
1.3.3 For Chief Strategy Officers
1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into
2 TECHNOLOGICAL TRENDS
2.1 Technological Adoption Rate
2.2 Current Trend Impact Analysis
2.3 Future Trend Impact Analysis
3 GLOBAL MARKET OUTLOOK
3.1 Market Pyramid Analysis
3.1.1 Introduction
3.1.2 Adjacent Market Opportunities
3.1.3 Ancillary Market Opportunities
3.2 Demand Side Analysis
3.2.1 Market Drivers: Impact Analysis
3.2.2 Market Restraints: Impact Analysis
3.2.3 Market Opportunities: Impact Analysis
3.2.4 Market Challenges: Impact Analysis
3.3 Supply Side Analysis
3.3.1 Porter’s Five Forces Analysis
3.3.1.1 Threat of New Entrants
3.3.1.2 Threat of New Substitutes
3.3.1.3 Bargaining Power of Suppliers
3.3.1.4 Bargaining Power of Buyers
3.3.1.5 Intensity of Competitive Rivalry
3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)
3.3.2.1 Political Landscape
3.3.2.2 Economic Landscape
3.3.2.3 Social Landscape
3.3.2.4 Component Landscape
3.3.3 Value Chain Analysis
3.3.4 Trend Analysis
3.3.5 Gap Analysis
3.3.6 Cost Analysis
4 GLOBAL AI IN PATHOLOGY MARKET, BY COMPONENT
4.1 Introduction
4.2 AI in Pathology Market: Component Scope Key Takeaways
4.3 Revenue Growth Analysis, 2023 & 2029
4.4 Software
4.4.1 Software Market Estimates and Forecast, 2021-2029 (USD Billion)
4.5 Hardware
4.5.1 Hardware Market Estimates and Forecast, 2021-2029 (USD Billion)
5 GLOBAL AI IN PATHOLOGY MARKET, BY NEURAL NETWORK
5.1 Introduction
5.2 AI in Pathology Market: Neural Network Scope Key Takeaways
5.3 Revenue Growth Analysis, 2023 & 2029
5.4 Generative Adversarial Networks (GANs)
5.4.1 Generative Adversarial Networks (GANs) Market Estimates and Forecast, 2021-2029 (USD Billion)
5.5 Convolutional Neural Networks (CNNs)
5.5.1 Convolutional Neural Networks (CNNs) Market Estimates and Forecast, 2021-2029 (USD Billion)
5.6 Recurrent Neural Networks (RNNs)
5.6.1 Recurrent Neural Networks (RNNs) Market Estimates and Forecast, 2021-2029 (USD Billion)
5.7 Others
5.7.1 Others Market Estimates and Forecast, 2021-2029 (USD Billion)
6 GLOBAL AI IN PATHOLOGY MARKET, BY APPLICATION
6.1 Introduction
6.2 AI in Pathology Market: Application Scope Key Takeaways
6.3 Revenue Growth Analysis, 2023 & 2029
6.4 Drug Discovery
6.4.1 Drug Discovery Market Estimates and Forecast, 2021-2029 (USD Billion)
6.5 Disease Diagnosis & Prognosis
6.5.1 Disease Diagnosis & Prognosis Market Estimates and Forecast, 2021-2029 (USD Billion)
6.6 Clinical Workflow
6.6.1 Clinical Workflow Market Estimates and Forecast, 2021-2029 (USD Billion)
6.7 Training & Education
6.7.1 Training & Education Market Estimates and Forecast, 2021-2029 (USD Billion)
7 GLOBAL AI IN PATHOLOGY MARKET, BY END USER
7.1 Introduction
7.2 AI in Pathology Market: End User Scope Key Takeaways
7.3 Revenue Growth Analysis, 2023 & 2029
7.4 Pharmaceutical & Biotechnology Companies
7.4.1 Pharmaceutical & Biotechnology Companies Market Estimates and Forecast, 2021-2029 (USD Billion)
7.5 Hospitals & Reference Laboratories
7.5.1 Hospitals & Reference Laboratories Market Estimates and Forecast, 2021-2029 (USD Billion)
7.6 Academic & Research Institutes
7.6.1 Academic & Research Institutes Market Estimates and Forecast, 2021-2029 (USD Billion)
8 GLOBAL AI IN PATHOLOGY MARKET, BY REGION
8.1 Introduction
8.2 North America AI in Pathology Market Estimates and Forecast, 2021-2029 (USD Billion)
8.2.1 By Component
8.2.2 By Neural Network
8.2.3 By Application
8.2.4 By End User
8.2.5 By Country
8.2.5.1 U.S. AI in Pathology Market Estimates and Forecast, 2021-2029 (USD Billion)
8.2.5.1.1 By Component
8.2.5.1.2 By Neural Network
8.2.5.1.3 By Application
8.2.5.1.4 By End User
8.2.5.2 Canada AI in Pathology Market Estimates and Forecast, 2021-2029 (USD Billion)
8.2.5.2.1 By Component
8.2.5.2.2 By Neural Network
8.2.5.2.3 By Application
8.2.5.2.4 By End User
8.2.5.3 Mexico AI in Pathology Market Estimates and Forecast, 2021-2029 (USD Billion)
8.2.5.3.1 By Component
8.2.5.3.2 By Neural Network
8.2.5.3.3 By Application
8.2.5.3.4 By End User
8.3 Europe AI in Pathology Market Estimates and Forecast, 2021-2029 (USD Billion)
8.3.1 By Component
8.3.2 By Neural Network
8.3.3 By Application
8.3.4 By End User
8.3.5 By Country
8.3.5.1 Germany AI in Pathology Market Estimates and Forecast, 2021-2029 (USD Billion)
8.3.5.1.1 By Component
8.3.5.1.2 By Neural Network
8.3.5.1.3 By Application
8.3.5.1.4 By End User
8.3.5.2 U.K. Presered Flowers Market Estimates and Forecast, 2021-2029 (USD Billion)
8.3.5.2.1 By Component
8.3.5.2.2 By Neural Network
8.3.5.2.3 By Application
8.3.5.2.4 By End User
8.3.5.3 France AI in Pathology Market Estimates and Forecast, 2021-2029 (USD Billion)
8.3.5.3.1 By Component
8.3.5.3.2 By Neural Network
8.3.5.3.3 By Application
8.3.5.3.4 By End User
8.3.5.4 Italy AI in Pathology Market Estimates and Forecast, 2021-2029 (USD Billion)
8.3.5.4.1 By Component
8.3.5.4.2 By Neural Network
8.3.5.4.3 By Application
8.3.5.4.4 By End User
8.3.5.5 Spain AI in Pathology Market Estimates and Forecast, 2021-2029 (USD Billion)
8.3.5.5.1 By Component
8.3.5.5.2 By Neural Network
8.3.5.5.3 By Application
8.3.5.5.4 By End User
8.3.5.6 Netherlands AI in Pathology Market Estimates and Forecast, 2021-2029 (USD Billion)
8.3.5.6.1 By Component
8.3.5.6.2 By Neural Network
8.3.5.6.3 By Application
8.3.5.6.4 By End User
8.3.5.7 Rest of Europe AI in Pathology Market Estimates and Forecast, 2021-2029 (USD Billion)
8.3.5.7.1 By Component
8.3.5.7.2 By Neural Network
8.3.5.7.3 By Application
8.3.5.7.4 By End User
8.4 Asia Pacific AI in Pathology Market Estimates and Forecast, 2021-2029 (USD Billion)
8.4.1 By Component
8.4.2 By Neural Network
8.4.3 By Application
8.4.4 By End User
8.4.5 By Country
8.4.5.1 China AI in Pathology Market Estimates and Forecast, 2021-2029 (USD Billion)
8.4.5.1.1 By Component
8.4.5.1.2 By Neural Network
8.4.5.1.3 By Application
8.4.5.1.4 By End User
8.4.5.2 Japan AI in Pathology Market Estimates and Forecast, 2021-2029 (USD Billion)
8.4.5.2.1 By Component
8.4.5.2.2 By Neural Network
8.4.5.2.3 By Application
8.4.5.2.4 By End User
8.4.5.3 India AI in Pathology Market Estimates and Forecast, 2021-2029 (USD Billion)
8.4.5.3.1 By Component
8.4.5.3.2 By Neural Network
8.4.5.3.3 By Application
8.4.5.3.4 By End User
8.4.5.4 South Korea AI in Pathology Market Estimates and Forecast, 2021-2029 (USD Billion)
8.4.5.4.1 By Component
8.4.5.4.2 By Neural Network
8.4.5.4.3 By Application
8.4.5.4.4 By End User
8.4.5.5 Singapore AI in Pathology Market Estimates and Forecast, 2021-2029 (USD Billion)
8.4.5.5.1 By Component
8.4.5.5.2 By Neural Network
8.4.5.5.3 By Application
8.4.5.5.4 By End User
8.4.5.6 Malaysia AI in Pathology Market Estimates and Forecast, 2021-2029 (USD Billion)
8.4.5.6.1 By Component
8.4.5.6.2 By Neural Network
8.4.5.6.3 By Application
8.4.5.6.4 By End User
8.4.5.7 Thailand AI in Pathology Market Estimates and Forecast, 2021-2029 (USD Billion)
8.4.5.7.1 By Component
8.4.5.7.2 By Neural Network
8.4.5.7.3 By Application
8.4.5.7.4 By End User
8.4.5.8 Indonesia AI in Pathology Market Estimates and Forecast, 2021-2029 (USD Billion)
8.4.5.8.1 By Component
8.4.5.8.2 By Neural Network
8.4.5.8.3 By Application
8.4.5.8.4 By End User
8.4.5.9 Vietnam AI in Pathology Market Estimates and Forecast, 2021-2029 (USD Billion)
8.4.5.9.1 By Component
8.4.5.9.2 By Neural Network
8.4.5.9.3 By Application
8.4.5.9.4 By End User
8.4.5.10 Taiwan AI in Pathology Market Estimates and Forecast, 2021-2029 (USD Billion)
8.4.5.10.1 By Component
8.4.5.10.2 By Neural Network
8.4.5.10.3 By Application
8.4.5.10.4 By End User
8.4.5.11 Rest of Asia Pacific AI in Pathology Market Estimates and Forecast, 2021-2029 (USD Billion)
8.4.5.11.1 By Component
8.4.5.11.2 By Neural Network
8.4.5.11.3 By Application
8.4.5.11.4 By End User
8.5 Middle East and Africa AI in Pathology Market Estimates and Forecast, 2021-2029 (USD Billion)
8.5.1 By Component
8.5.2 By Neural Network
8.5.3 By Application
8.5.4 By End User
8.5.5 By Country
8.5.5.1 Saudi Arabia AI in Pathology Market Estimates and Forecast, 2021-2029 (USD Billion)
8.5.5.1.1 By Component
8.5.5.1.2 By Neural Network
8.5.5.1.3 By Application
8.5.5.1.4 By End User
8.5.5.2 U.A.E. AI in Pathology Market Estimates and Forecast, 2021-2029 (USD Billion)
8.5.5.2.1 By Component
8.5.5.2.2 By Neural Network
8.5.5.2.3 By Application
8.5.5.2.4 By End User
8.5.5.3 Israel AI in Pathology Market Estimates and Forecast, 2021-2029 (USD Billion)
8.5.4.3.1 By Component
8.5.4.3.2 By Neural Network
8.5.4.3.3 By Application
8.5.5.3.4 By End User
8.5.5.4 South Africa AI in Pathology Market Estimates and Forecast, 2021-2029 (USD Billion)
8.5.5.4.1 By Component
8.5.5.4.2 By Neural Network
8.5.5.4.3 By Application
8.5.5.4.4 By End User
8.5.5.5 Rest of Middle East and Africa AI in Pathology Market Estimates and Forecast, 2021-2029 (USD Billion)
8.5.5.5.1 By Component
8.5.5.5.2 By Neural Network
8.5.5.5.2 By Application
8.5.5.5.4 By End User
8.6 Central & South America AI in Pathology Market Estimates and Forecast, 2021-2029 (USD Billion)
8.6.1 By Component
8.6.2 By Neural Network
8.6.3 By Application
8.6.4 By End User
8.6.5 By Country
8.6.5.1 Brazil AI in Pathology Market Estimates and Forecast, 2021-2029 (USD Billion)
8.6.5.1.1 By Component
8.6.5.1.2 By Neural Network
8.6.5.1.3 By Application
8.6.5.1.4 By End User
8.6.5.2 Argentina AI in Pathology Market Estimates and Forecast, 2021-2029 (USD Billion)
8.6.5.2.1 By Component
8.6.5.2.2 By Neural Network
8.6.5.2.3 By Application
8.6.5.2.4 By End User
8.6.5.3 Chile AI in Pathology Market Estimates and Forecast, 2021-2029 (USD Billion)
8.6.5.3.1 By Component
8.6.5.3.2 By Neural Network
8.6.5.3.3 By Application
8.6.5.5.4 By End User
8.6.5.4 Rest of Central & South America AI in Pathology Market Estimates and Forecast, 2021-2029 (USD Billion)
8.6.5.4.1 By Component
8.6.5.4.2 By Neural Network
8.6.5.4.3 By Application
8.6.5.4.4 By End User
9 COMPETITIVE LANDCAPE
9.1 Company Market Share Analysis
9.2 Four Quadrant Positioning Matrix
9.2.1 Market Leaders
9.2.2 Market Visionaries
9.2.3 Market Challengers
9.2.4 Niche Market Players
9.3 Vendor Landscape
9.3.1 North America
9.3.2 Europe
9.3.3 Asia Pacific
9.3.4 Rest of the World
9.4 Company Profiles
9.4.1 F. Hoffmann-La Roche Ltd
9.4.1.1 Business Description & Financial Analysis
9.4.1.2 SWOT Analysis
9.4.1.3 Products & Services Offered
9.4.1.4 Strategic Alliances between Business Partners
9.4.2 Akoya Biosciences, Inc.
9.4.2.1 Business Description & Financial Analysis
9.4.2.2 SWOT Analysis
9.4.2.3 Products & Services Offered
9.4.2.4 Strategic Alliances between Business Partners
9.4.3 Aiforia Technologies Plc
9.4.3.1 Business Description & Financial Analysis
9.4.3.2 SWOT Analysis
9.4.3.3 Products & Services Offered
9.4.3.4 Strategic Alliances between Business Partners
9.4.4 Hologic, Inc.
9.4.4.1 Business Description & Financial Analysis
9.4.4.2 SWOT Analysis
9.4.4.3 Products & Services Offered
9.4.4.4 Strategic Alliances between Business Partners
9.4.5 Indica Labs Inc.
9.4.5.1 Business Description & Financial Analysis
9.4.5.2 SWOT Analysis
9.4.5.3 Products & Services Offered
9.4.5.4 Strategic Alliances between Business Partners
9.4.6 KONINKLIJKE PHILIPS N.V.
9.4.6.1 Business Description & Financial Analysis
9.4.6.2 SWOT Analysis
9.4.6.3 Products & Services Offered
9.4.6.4 Strategic Alliances between Business Partners
9.4.7 OptraScan
9.4.7.1 Business Description & Financial Analysis
9.4.7.2 SWOT Analysis
9.4.7.3 Products & Services Offered
9.4.8.4 Strategic Alliances between Business Partners
9.4.8 Ibex Medical Analytics Ltd.
9.4.8.1 Business Description & Financial Analysis
9.4.8.2 SWOT Analysis
9.4.8.3 Products & Services Offered
9.4.8.4 Strategic Alliances between Business Partners
9.4.9 Mindpeak GmbH
9.4.9.1 Business Description & Financial Analysis
9.4.9.2 SWOT Analysis
9.4.9.3 Products & Services Offered
9.4.9.4 Strategic Alliances between Business Partners
9.4.10 Tribun Health
9.4.10.1 Business Description & Financial Analysis
9.4.10.2 SWOT Analysis
9.4.10.3 Products & Services Offered
9.4.10.4 Strategic Alliances between Business Partners
9.4.11 Other Companies
9.4.11.1 Business Description & Financial Analysis
9.4.11.2 SWOT Analysis
9.4.11.3 Products & Services Offered
9.4.11.4 Strategic Alliances between Business Partners
10 RESEARCH METHODOLOGY
10.1 Market Introduction
10.1.1 Market Definition
10.1.2 Market Scope & Segmentation
10.2 Information Procurement
10.2.1 Secondary Research
10.2.1.1 Purchased Databases
10.2.1.2 GMEs Internal Data Repository
10.2.1.3 Secondary Resources & Third Party Perspectives
10.2.1.4 Company Information Sources
10.2.2 Primary Research
10.2.2.1 Various Types of Respondents for Primary Interviews
10.2.2.2 Number of Interviews Conducted throughout the Research Process
10.2.2.3 Primary Stakeholders
10.2.2.4 Discussion Guide for Primary Participants
10.2.3 Expert Panels
10.2.3.1 Expert Panels Across 30+ Industry
10.2.4 Paid Local Experts
10.2.4.1 Paid Local Experts Across 30+ Industry Across each Region
10.3 Market Estimation
10.3.1 Top-Down Approach
10.3.1.1 Macro-Economic Indicators Considered
10.3.1.2 Micro-Economic Indicators Considered
10.3.2 Bottom Up Approach
10.3.2.1 Company Share Analysis Approach
10.3.2.2 Estimation of Potential Product Sales
10.4 Data Triangulation
10.4.1 Data Collection
10.4.2 Time Series, Cross Sectional & Panel Data Analysis
10.4.3 Cluster Analysis
10.5 Analysis and Output
10.5.1 Inhouse AI Based Real Time Analytics Tool
10.5.2 Output From Desk & Primary Research
10.6 Research Assumptions & Limitations
10.7.1 Research Assumptions
10.7.2 Research Limitations
LIST OF TABLES
1 Global AI in Pathology Market, By Component, 2021-2029 (USD Billion)
2 Software Market, By Region, 2021-2029 (USD Billion)
3 Hardware Market, By Region, 2021-2029 (USD Billion)
4 Global AI in Pathology Market, By Neural Network, 2021-2029 (USD Billion)
5 Generative Adversarial Networks (GANs) Market, By Region, 2021-2029 (USD Billion)
6 Convolutional Neural Networks (CNNs) Market, By Region, 2021-2029 (USD Billion)
7 Recurrent Neural Networks (RNNs) Market, By Region, 2021-2029 (USD Billion)
8 Others Market, By Region, 2021-2029 (USD Billion)
9 Global AI in Pathology Market, By Application, 2021-2029 (USD Billion)
10 Drug Discovery Market, By Region, 2021-2029 (USD Billion)
11 Disease Diagnosis & Prognosis Market, By Region, 2021-2029 (USD Billion)
12 Clinical Workflow Market, By Region, 2021-2029 (USD Billion)
13 Training & Education Market, By Region, 2021-2029 (USD Billion)
14 Global AI in Pathology Market, By END USER, 2021-2029 (USD Billion)
15 Pharmaceutical & Biotechnology Companies Market, By Region, 2021-2029 (USD Billion)
16 Hospitals & Reference Laboratories Market, By Region, 2021-2029 (USD Billion)
17 Academic & Research Institutes Market, By Region, 2021-2029 (USD Billion)
18 Regional Analysis, 2021-2029 (USD Billion)
19 North America AI in Pathology Market, By Component, 2021-2029 (USD Billion)
20 North America AI in Pathology Market, By Neural Network, 2021-2029 (USD Billion)
21 North America AI in Pathology Market, By Application, 2021-2029 (USD Billion)
22 North America AI in Pathology Market, By End User, 2021-2029 (USD Billion)
23 North America AI in Pathology Market, By Country, 2021-2029 (USD Billion)
24 U.S AI in Pathology Market, By Component, 2021-2029 (USD Billion)
25 U.S AI in Pathology Market, By Neural Network, 2021-2029 (USD Billion)
26 U.S AI in Pathology Market, By Application, 2021-2029 (USD Billion)
27 U.S AI in Pathology Market, By End User, 2021-2029 (USD Billion)
28 Canada AI in Pathology Market, By Component, 2021-2029 (USD Billion)
29 Canada AI in Pathology Market, By Neural Network, 2021-2029 (USD Billion)
30 Canada AI in Pathology Market, By Application, 2021-2029 (USD Billion)
31 CANADA AI in Pathology Market, By End User, 2021-2029 (USD Billion)
32 Mexico AI in Pathology Market, By Component, 2021-2029 (USD Billion)
33 Mexico AI in Pathology Market, By Neural Network, 2021-2029 (USD Billion)
34 Mexico AI in Pathology Market, By Application, 2021-2029 (USD Billion)
35 mexico AI in Pathology Market, By End User, 2021-2029 (USD Billion)
36 Europe AI in Pathology Market, By Component, 2021-2029 (USD Billion)
37 Europe AI in Pathology Market, By Neural Network, 2021-2029 (USD Billion)
38 Europe AI in Pathology Market, By Application, 2021-2029 (USD Billion)
39 europe AI in Pathology Market, By End User, 2021-2029 (USD Billion)
40 europe AI in Pathology Market, By COUNTRY, 2021-2029 (USD Billion)
41 Germany AI in Pathology Market, By Component, 2021-2029 (USD Billion)
42 Germany AI in Pathology Market, By Neural Network, 2021-2029 (USD Billion)
43 Germany AI in Pathology Market, By Application, 2021-2029 (USD Billion)
44 germany AI in Pathology Market, By End User, 2021-2029 (USD Billion)
45 UK AI in Pathology Market, By Component, 2021-2029 (USD Billion)
46 UK AI in Pathology Market, By Neural Network, 2021-2029 (USD Billion)
47 UK AI in Pathology Market, By Application, 2021-2029 (USD Billion)
48 U.kAI in Pathology Market, By End User, 2021-2029 (USD Billion)
49 France AI in Pathology Market, By Component, 2021-2029 (USD Billion)
50 France AI in Pathology Market, By Neural Network, 2021-2029 (USD Billion)
51 France AI in Pathology Market, By Application, 2021-2029 (USD Billion)
52 france AI in Pathology Market, By End User, 2021-2029 (USD Billion)
53 Italy AI in Pathology Market, By Component, 2021-2029 (USD Billion)
54 Italy AI in Pathology Market, By T Neural Network Type, 2021-2029 (USD Billion)
55 Italy AI in Pathology Market, By Application, 2021-2029 (USD Billion)
56 italy AI in Pathology Market, By End User, 2021-2029 (USD Billion)
57 Spain AI in Pathology Market, By Component, 2021-2029 (USD Billion)
58 Spain AI in Pathology Market, By Neural Network, 2021-2029 (USD Billion)
59 Spain AI in Pathology Market, By Application, 2021-2029 (USD Billion)
60 spain AI in Pathology Market, By End User, 2021-2029 (USD Billion)
61 Netherlands AI in Pathology Market, By Component, 2021-2029 (USD Billion)
62 Netherlands AI in Pathology Market, By Neural Network, 2021-2029 (USD Billion)
63 Netherlands AI in Pathology Market, By Application, 2021-2029 (USD Billion)
64 Netherlands AI in Pathology Market, By END USER, 2021-2029 (USD Billion)
65 Rest Of Europe AI in Pathology Market, By Component, 2021-2029 (USD Billion)
66 Rest Of Europe AI in Pathology Market, By Neural Network, 2021-2029 (USD Billion)
67 Rest of Europe AI in Pathology Market, By Application, 2021-2029 (USD Billion)
68 REST OF EUROPE AI in Pathology Market, By End User, 2021-2029 (USD Billion)
69 Asia Pacific AI in Pathology Market, By Component, 2021-2029 (USD Billion)
70 Asia Pacific AI in Pathology Market, By Neural Network, 2021-2029 (USD Billion)
71 Asia Pacific AI in Pathology Market, By Application, 2021-2029 (USD Billion)
72 asia AI in Pathology Market, By End User, 2021-2029 (USD Billion)
73 Asia Pacific AI in Pathology Market, By Country, 2021-2029 (USD Billion)
74 China AI in Pathology Market, By Component, 2021-2029 (USD Billion)
75 China AI in Pathology Market, By Neural Network, 2021-2029 (USD Billion)
76 China AI in Pathology Market, By Application, 2021-2029 (USD Billion)
77 china AI in Pathology Market, By End User, 2021-2029 (USD Billion)
78 India AI in Pathology Market, By Component, 2021-2029 (USD Billion)
79 India AI in Pathology Market, By Neural Network, 2021-2029 (USD Billion)
80 India AI in Pathology Market, By Application, 2021-2029 (USD Billion)
81 india AI in Pathology Market, By End User, 2021-2029 (USD Billion)
82 Japan AI in Pathology Market, By Component, 2021-2029 (USD Billion)
83 Japan AI in Pathology Market, By Neural Network, 2021-2029 (USD Billion)
84 Japan AI in Pathology Market, By Application, 2021-2029 (USD Billion)
85 japan AI in Pathology Market, By End User, 2021-2029 (USD Billion)
86 South Korea AI in Pathology Market, By Component, 2021-2029 (USD Billion)
87 South Korea AI in Pathology Market, By Neural Network, 2021-2029 (USD Billion)
88 South Korea AI in Pathology Market, By Application, 2021-2029 (USD Billion)
89 south korea AI in Pathology Market, By End User, 2021-2029 (USD Billion)
90 Singapore AI in Pathology Market, By Component, 2021-2029 (USD Billion)
91 Singapore AI in Pathology Market, By Neural Network, 2021-2029 (USD Billion)
92 Singapore AI in Pathology Market, By Application, 2021-2029 (USD Billion)
93 Singapore AI in Pathology Market, By End User, 2021-2029 (USD Billion)
94 Thailand AI in Pathology Market, By Component, 2021-2029 (USD Billion)
95 Thailand AI in Pathology Market, By Neural Network, 2021-2029 (USD Billion)
96 Thailand AI in Pathology Market, By Application, 2021-2029 (USD Billion)
97 Thailand AI in Pathology Market, By End User, 2021-2029 (USD Billion)
98 MALAYSIA AI in Pathology Market, By Component, 2021-2029 (USD Billion)
99 MALAYSIA AI in Pathology Market, By Neural Network, 2021-2029 (USD Billion)
100 MALAYSIA AI in Pathology Market, By Application, 2021-2029 (USD Billion)
101 MALAYSIA AI in Pathology Market, By End User, 2021-2029 (USD Billion)
102 Vietnam AI in Pathology Market, By Component, 2021-2029 (USD Billion)
103 Vietnam AI in Pathology Market, By Neural Network, 2021-2029 (USD Billion)
104 Vietnam AI in Pathology Market, By Application, 2021-2029 (USD Billion)
105 Taiwan AI in Pathology Market, By Component, 2021-2029 (USD Billion)
106 Taiwan AI in Pathology Market, By Neural Network, 2021-2029 (USD Billion)
107 Taiwan AI in Pathology Market, By Application, 2021-2029 (USD Billion)
108 Taiwan AI in Pathology Market, By End User, 2021-2029 (USD Billion)
109 REST OF APAC AI in Pathology Market, By Component, 2021-2029 (USD Billion)
110 REST OF APAC AI in Pathology Market, By Neural Network, 2021-2029 (USD Billion)
111 REST OF APAC AI in Pathology Market, By Application, 2021-2029 (USD Billion)
112 Rest of APAC AI in Pathology Market, By End User, 2021-2029 (USD Billion)
113 Middle East and Africa AI in Pathology Market, By Component, 2021-2029 (USD Billion)
114 Middle East and Africa AI in Pathology Market, By Neural Network, 2021-2029 (USD Billion)
115 Middle East and Africa AI in Pathology Market, By Application, 2021-2029 (USD Billion)
116 MIDDLE EAST AND AFRICA AI in Pathology Market, By End User, 2021-2029 (USD Billion)
117 Middle East and Africa AI in Pathology Market, By Country, 2021-2029 (USD Billion)
118 Saudi Arabia AI in Pathology Market, By Component, 2021-2029 (USD Billion)
119 Saudi Arabia AI in Pathology Market, By Neural Network, 2021-2029 (USD Billion)
120 Saudi Arabia AI in Pathology Market, By Application, 2021-2029 (USD Billion)
121 saudi arabia AI in Pathology Market, By End User, 2021-2029 (USD Billion)
122 UAE AI in Pathology Market, By Component, 2021-2029 (USD Billion)
123 UAE AI in Pathology Market, By Neural Network, 2021-2029 (USD Billion)
124 UAE AI in Pathology Market, By Application, 2021-2029 (USD Billion)
125 uae AI in Pathology Market, By End User, 2021-2029 (USD Billion)
126 Israel AI in Pathology Market, By Component, 2021-2029 (USD Billion)
127 Israel AI in Pathology Market, By Neural Network, 2021-2029 (USD Billion)
128 Israel AI in Pathology Market, By Application, 2021-2029 (USD Billion)
129 Israel AI in Pathology Market, By End User, 2021-2029 (USD Billion)
130 South Africa AI in Pathology Market, By Component, 2021-2029 (USD Billion)
131 South Africa AI in Pathology Market, By Neural Network, 2021-2029 (USD Billion)
132 South Africa AI in Pathology Market, By Application, 2021-2029 (USD Billion)
133 South Africa AI in Pathology Market, By End User, 2021-2029 (USD Billion)
134 REST OF MIDDLE EAST AND AFRICA AI in Pathology Market, By Component, 2021-2029 (USD Billion)
135 REST OF MIDDLE EAST AND AFRICA AI in Pathology Market, By Neural Network, 2021-2029 (USD Billion)
136 REST OF MIDDLE EAST AND AFRICA AI in Pathology Market, By Application, 2021-2029 (USD Billion)
137 REST OF MIDDLE EAST AND AFRICA AI in Pathology Market, By End User, 2021-2029 (USD Billion)
138 Central & South America AI in Pathology Market, By Component, 2021-2029 (USD Billion)
139 Central & South America AI in Pathology Market, By Neural Network, 2021-2029 (USD Billion)
140 Central & South America AI in Pathology Market, By Application, 2021-2029 (USD Billion)
141 CENTRAL & SOUTH AMERICA AI in Pathology Market, By End User, 2021-2029 (USD Billion)
142 Central & South America AI in Pathology Market, By Country, 2021-2029 (USD Billion)
143 Brazil AI in Pathology Market, By Component, 2021-2029 (USD Billion)
144 Brazil AI in Pathology Market, By Neural Network, 2021-2029 (USD Billion)
145 Brazil AI in Pathology Market, By Application, 2021-2029 (USD Billion)
146 brazil AI in Pathology Market, By End User, 2021-2029 (USD Billion)
147 Chile AI in Pathology Market, By Component, 2021-2029 (USD Billion)
148 Chile AI in Pathology Market, By Neural Network, 2021-2029 (USD Billion)
149 Chile AI in Pathology Market, By Application, 2021-2029 (USD Billion)
150 Chile AI in Pathology Market, By End User, 2021-2029 (USD Billion)
151 Argentina AI in Pathology Market, By Component, 2021-2029 (USD Billion)
152 Argentina AI in Pathology Market, By Neural Network, 2021-2029 (USD Billion)
153 Argentina AI in Pathology Market, By Application, 2021-2029 (USD Billion)
154 Argentina AI in Pathology Market, By End User, 2021-2029 (USD Billion)
155 REST OF CENTRAL AND SOUTH AMERICA AI in Pathology Market, By Component, 2021-2029 (USD Billion)
156 REST OF CENTRAL AND SOUTH AMERICA AI in Pathology Market, By Neural Network, 2021-2029 (USD Billion)
157 REST OF CENTRAL AND SOUTH AMERICA AI in Pathology Market, By Application, 2021-2029 (USD Billion)
158 REST OF CENTRAL AND SOUTH AMERICA AI in Pathology Market, By End User, 2021-2029 (USD Billion)
159 F. Hoffmann-La Roche Ltd: Products & Services Offering
160 Akoya Biosciences, Inc.: Products & Services Offering
161 Aiforia Technologies Plc: Products & Services Offering
162 Hologic, Inc.: Products & Services Offering
163 Indica Labs Inc.: Products & Services Offering
164 KONINKLIJKE PHILIPS N.V.: Products & Services Offering
165 OptraScan: Products & Services Offering
166 Ibex Medical Analytics Ltd.: Products & Services Offering
167 Mindpeak GmbH, Inc: Products & Services Offering
168 Tribun Health: Products & Services Offering
169 Other Companies: Products & Services Offering
LIST OF FIGURES
1 Global AI in Pathology Market Overview
2 Global AI in Pathology Market Value From 2021-2029 (USD Billion)
3 Global AI in Pathology Market Share, By Component (2023)
4 Global AI in Pathology Market Share, By Neural Network (2023)
5 Global AI in Pathology Market Share, By Application (2023)
6 Global AI in Pathology Market Share, By End User (2023)
7 Global AI in Pathology Market, By Region (Asia Pacific Market)
8 Technological Trends In Global AI in Pathology Market
9 Four Quadrant Competitor Positioning Matrix
10 Impact Of Macro & Micro Indicators On The Market
11 Impact Of Key Drivers On The Global AI in Pathology Market
12 Impact Of Challenges On The Global AI in Pathology Market
13 Porter’s Five Forces Analysis
14 Global AI in Pathology Market: By Component Scope Key Takeaways
15 Global AI in Pathology Market, By Component Segment: Revenue Growth Analysis
16 Software Market, By Region, 2021-2029 (USD Billion)
17 Hardware Market, By Region, 2021-2029 (USD Billion)
18 Global AI in Pathology Market: By Neural Network Scope Key Takeaways
19 Global AI in Pathology Market, By Neural Network Segment: Revenue Growth Analysis
20 Generative Adversarial Networks (GANs) Market, By Region, 2021-2029 (USD Billion)
21 Convolutional Neural Networks (CNNs) Market, By Region, 2021-2029 (USD Billion)
22 Recurrent Neural Networks (RNNs) Market, By Region, 2021-2029 (USD Billion)
23 Others Market, By Region, 2021-2029 (USD Billion)
24 Global AI in Pathology Market: By Application Scope Key Takeaways
25 Global AI in Pathology Market, By Application Segment: Revenue Growth Analysis
26 Drug Discovery Market, By Region, 2021-2029 (USD Billion)
27 Disease Diagnosis & Prognosis Market, By Region, 2021-2029 (USD Billion)
28 Clinical Workflow Market, By Region, 2021-2029 (USD Billion)
29 Training & Education Market, By Region, 2021-2029 (USD Billion)
30 Global AI in Pathology Market: By End User Scope Key Takeaways
31 Global AI in Pathology Market, By End User Segment: Revenue Growth Analysis
32 Pharmaceutical & Biotechnology Companies Market, By Region, 2021-2029 (USD Billion)
33 Hospitals & Reference Laboratories Market, By Region, 2021-2029 (USD Billion)
34 Academic & Research Institutes Market, By Region, 2021-2029 (USD Billion)
35 Regional Segment: Revenue Growth Analysis
36 Global AI in Pathology Market: Regional Analysis
37 North America AI in Pathology Market Overview
38 North America AI in Pathology Market, By Component
39 North America AI in Pathology Market, By Neural Network
40 North America AI in Pathology Market, By Application
41 North America AI in Pathology Market, By End User
42 North America AI in Pathology Market, By Country
43 U.S. AI in Pathology Market, By Component
44 U.S. AI in Pathology Market, By Neural Network
45 U.S. AI in Pathology Market, By Application
46 U.S. AI in Pathology Market, By End User
47 Canada AI in Pathology Market, By Component
48 Canada AI in Pathology Market, By Neural Network
49 Canada AI in Pathology Market, By Application
50 Canada AI in Pathology Market, By End User
51 Mexico AI in Pathology Market, By Component
52 Mexico AI in Pathology Market, By Neural Network
53 Mexico AI in Pathology Market, By Application
54 Mexico AI in Pathology Market, By End User
55 Four Quadrant Positioning Matrix
56 Company Market Share Analysis
57 F. Hoffmann-La Roche Ltd: Company Snapshot
58 F. Hoffmann-La Roche Ltd: SWOT Analysis
59 F. Hoffmann-La Roche Ltd: Geographic Presence
60 Akoya Biosciences, Inc.: Company Snapshot
61 Akoya Biosciences, Inc.: SWOT Analysis
62 Akoya Biosciences, Inc.: Geographic Presence
63 Aiforia Technologies Plc: Company Snapshot
64 Aiforia Technologies Plc: SWOT Analysis
65 Aiforia Technologies Plc: Geographic Presence
66 Hologic, Inc.: Company Snapshot
67 Hologic, Inc.: Swot Analysis
68 Hologic, Inc.: Geographic Presence
69 Indica Labs Inc.: Company Snapshot
70 Indica Labs Inc.: SWOT Analysis
71 Indica Labs Inc.: Geographic Presence
72 KONINKLIJKE PHILIPS N.V.: Company Snapshot
73 KONINKLIJKE PHILIPS N.V.: SWOT Analysis
74 KONINKLIJKE PHILIPS N.V.: Geographic Presence
75 OptraScan: Company Snapshot
76 OptraScan: SWOT Analysis
77 OptraScan: Geographic Presence
78 Ibex Medical Analytics Ltd.: Company Snapshot
79 Ibex Medical Analytics Ltd.: SWOT Analysis
80 Ibex Medical Analytics Ltd.: Geographic Presence
81 Mindpeak GmbH, Inc.: Company Snapshot
82 Mindpeak GmbH, Inc.: SWOT Analysis
83 Mindpeak GmbH, Inc.: Geographic Presence
84 Tribun Health: Company Snapshot
85 Tribun Health: SWOT Analysis
86 Tribun Health: Geographic Presence
87 Other Companies: Company Snapshot
88 Other Companies: SWOT Analysis
89 Other Companies: Geographic Presence
The Global AI in Pathology Market has been studied from the year 2019 till 2029. However, the CAGR provided in the report is from the year 2024 to 2029. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the AI in Pathology Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
